CA Patent

CA2036618C — Fused thiophene derivatives, their production and use

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2002-10-29 · 24y expired

What this patent protects

Novel fused thiophene derivatives of the formula (I): (see formula I) wherein W is (see formula II) or (see formula III) R1 and R2 are each. H, halogen, cyano, nitro, acylamino, or a hydrocarbon residue; R3 is H, optionally substituted alkyl or alkenyl, or -COD wherein D is H, a…

USPTO Abstract

Novel fused thiophene derivatives of the formula (I): (see formula I) wherein W is (see formula II) or (see formula III) R1 and R2 are each. H, halogen, cyano, nitro, acylamino, or a hydrocarbon residue; R3 is H, optionally substituted alkyl or alkenyl, or -COD wherein D is H, alkoxy, hydroxy, halogen, or optionally substituted amino; R4 is H, halogen or nitro; R5 is a residue capable of forming or convertible into an anion; R6 is H or optionally substituted alkyl or alkenyl; R7 is a hydrocarbon residue; A is a bond or a spacer; and n is 1 or 2; have potent angiotensin II antagonist activity and antihypertensive activity, thus being useful as therapeutic agents for treating circulatory system diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2036618C
Jurisdiction
CA
Classification
Expires
2002-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.